Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0836-2025Class II

Idylla INSTRUMENT, IVD, REF P0010. Intended for the detection of nucleic acid targets in various types of...

Biocartis NV / initiated 2024-12-10 / Open, Classified / root cause: manufacturing process

Biocartis Nv began a recall of Idylla INSTRUMENT, IVD, REF P0010. Intended for the detection of nucleic acid targets in various types of human samples, using disposable Test-specific ldylla... on . FDA classified it as Class II and gives the reason as "False-positive MSI-H results generated by the Idylla MSI Test". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0836-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Biocartis NV
Product
Idylla INSTRUMENT, IVD, REF P0010. Intended for the detection of nucleic acid targets in various types of human samples, using disposable Test-specific ldylla Cartridges.
Product code
OOI Real Time Nucleic Acid Amplification System
Reason for recall
False-positive MSI-H results generated by the Idylla MSI Test.
Root cause tag
manufacturing process
FDA root cause
Environmental control
Action
Biocartis issued an URGENT - Medical Device Correction notice to its consignees on 12/10/2024 via email. The notice provided the description of the problem, its impact, and requested the following actions be taken: 1. Until your Instrument is serviced, please move forward with the option that applies to your situation: o In case you have another Idylla Instrument available that is not affected, use that Instrument to run the Idylla MSI Test and discontinue running the Idylla MSI Test on the listed Instrument(s). o No new Idylla MSI testing should be performed using the affected Idylla Instruments. o For results already obtained using an affected Idylla Instrument, the following apply: o MSS results are VALID and may be reported. o MSI-H (Microsatellite Instability High) results with six or seven positive identified biomarkers (as depicted in the result report) are VALID and may be reported. o MSI-H results other than those with six or seven positive identified biomarkers are INVALID and should NOT be reported or used to manage patient health. Patient samples with these results should be re-tested on an Idylla Instrument that is NOT affected. 2. If you are not the Idylla user, please forward this notice to the Idylla end user or Idylla supervisor and provide Biocartis with the correct contact details for our record keeping. 3. Completion of the Acknowledgement of Receipt (Appendix 2) is required for compliance. Please complete and sign the attached Acknowledgement of Receipt form by December 17, 2024, and send it to [email protected].
Quantity in commerce
8 units
Distribution
US: AL, NJ, TX, OH, CA
Product codes and lots
UDI/DI 05415219000119, Serial Numbers: 00002706, 00002820, 00003103, 00003262, 00003419, 00003434, 00003444, and 00003445.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0836-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0836-2025Class IIOngoingVoluntary: Firm initiated